Figure 2

Chondrogenic re-differentiation potential of chondrocytes after monolayer culture: Comparison between osteoarthritis and young adult patients

Kazuki Oishi*, Shusa Ohshika, Ken-Ichi Frukawa, Eiichi Tsuda, Yuji Yamamoto and Yasuyuki Ishibashi

Published: 27 March, 2019 | Volume 4 - Issue 1 | Pages: 016-023

Expression of chondrogenic related genes in non-OAC (A), OAC (B), and OAC / non-OAC (C). Quantification of gene expression of COL1, COL2, COL10, SOX9, and AGCN was estimated by real-time PCR analysis. Data represent an average of five independent experiments ± SD. A: The results of non-OAC are expressed as the fold increase of expression in relation to passage 1 of non-OAC. B: The results of OAC are expressed as the fold increase of expression in relation to passage 1 of OAC. C: The results are expressed as the fold increase of expression corresponding to non-OAC at the same passages or pellet culture.* P<0.05 vs P1, † P<0.05 vs P2, # P<0.05 vs P3, by ANOVA. § P<0.05 vs non-OAC, by Mann-Whitney U-test OAC: chondrocyte from osteoarthritis patients, non-OAC; chondrocyte from young adult patient.

" alt="jsmt-aid1038-g002"class="img-responsive img-rounded " style="cursor:pointer">

Figure 2:

Expression of chondrogenic related genes in non-OAC (A), OAC (B), and OAC / non-OAC (C). Quantification of gene expression of COL1, COL2, COL10, SOX9, and AGCN was estimated by real-time PCR analysis. Data represent an average of five independent experiments ± SD. A: The results of non-OAC are expressed as the fold increase of expression in relation to passage 1 of non-OAC. B: The results of OAC are expressed as the fold increase of expression in relation to passage 1 of OAC. C: The results are expressed as the fold increase of expression corresponding to non-OAC at the same passages or pellet culture.* P<0.05 vs P1, † P<0.05 vs P2, # P<0.05 vs P3, by ANOVA. § P<0.05 vs non-OAC, by Mann-Whitney U-test OAC: chondrocyte from osteoarthritis patients, non-OAC; chondrocyte from young adult patient.

Read Full Article HTML DOI: 10.29328/journal.jsmt.1001038 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

  • Exophthalmos Revealing a Spheno Temporo Orbital Meningioma
    Hassina S*, Krichene MA, Hazil Z, Bekkar B, Hasnaoui I, Robbana L, Bardi S, Akkanour Y, Serghini L and Abdallah EL Hassina S*, Krichene MA, Hazil Z, Bekkar B, Hasnaoui I, Robbana L, Bardi S, Akkanour Y, Serghini L, Abdallah EL. Exophthalmos Revealing a Spheno Temporo Orbital Meningioma. Int J Clin Exp Ophthalmol. 2024: doi: 10.29328/journal.ijceo.1001055; 8: 001-003
  • Enhancing Physiotherapy Outcomes with Photobiomodulation: A Comprehensive Review
    Nivaldo Antonio Parizotto* and Cleber Ferraresi Nivaldo Antonio Parizotto*, Cleber Ferraresi. Enhancing Physiotherapy Outcomes with Photobiomodulation: A Comprehensive Review. J Nov Physiother Rehabil. 2024: doi: 10.29328/journal.jnpr.1001061; 8: 031-038
  • Water Purification Using Ceramic Pots Water Filter
    Olaoluwa Ayobami Ogunkunle*, Oluwamumiyo Dorcas Adeojo and Olamide Christianah Idowu Olaoluwa Ayobami Ogunkunle*, Oluwamumiyo Dorcas Adeojo, Olamide Christianah Idowu. Water Purification Using Ceramic Pots Water Filter. Ann Adv Chem. 2023: doi: 10.29328/journal.aac.1001044; 7: 057-063
  • Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas
    Rasha Mokhtar Abdelkareem*, Afaf T Elnashar, Khaled Nasser Fadle and Eman MS Muhammad Rasha Mokhtar Abdelkareem*,Afaf T Elnashar,Khaled Nasser Fadle,Eman MS Muhammad. Immunohistochemical expression of Nestin as Cancer Stem Cell Marker in gliomas. J Neurosci Neurol Disord. 2019: doi: 10.29328/journal.jnnd.1001027; 3: 162-166
  • Pediatric Dysgerminoma: Unveiling a Rare Ovarian Tumor
    Faten Limaiem*, Khalil Saffar and Ahmed Halouani Faten Limaiem*, Khalil Saffar, Ahmed Halouani. Pediatric Dysgerminoma: Unveiling a Rare Ovarian Tumor. Arch Case Rep. 2024: doi: 10.29328/journal.acr.1001087; 8: 010-013

Read More

Most Viewed

Read More

Help ?